USA: A new study published in the Journal of Diabetes and Its Complications suggests that tirzepatide, a novel dual ...

Spraying pesticides for a living increases the risk of erectile dysfunction. Our denial of this fact may mask a deeper fear: ...

Tirzepatide significantly reduced the risk of progression to diabetes in adults with prediabetes and obesity or overweight.

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with lasting benefits and manageable side effects.

Postoperative penile hypoxia is one potential contributor, Pedersen and co-authors noted. The rationale for LI-SWT to treat ...

A study published in eClinicalMedicine found that tirzepatide outperforms semaglutide in reducing the risk of type 2 diabetes and major cardiovascular events among individuals with obesity, with ...

The primary purpose was to evaluate the long term effects of tirzepatide on body weight and on the risk of developing type 2 diabetes.

A three-year study of tirzepatide – a medication approved in the US as Mounjaro for diabetes and Zepbound for weight loss – found that when adults who had prediabetes and obesity or overweight ...

Eli Lilly and Company (NYSE: LLY) today announced detailed results from the SUMMIT Phase 3 trial showing tirzepatide significantly reduced the risk of worsening heart failure events in adults with ...

For the efficacy estimand ii, pooled doses of tirzepatide achieved significant results, demonstrating a 94% reduction in risk of progression to type 2 diabetes compared to placebo up to week 176.

Tirzepatide lowered the risk for progression to type 2 diabetes among adults with prediabetes and overweight or obesity in the SURMOUNT-1 3-year trial.